生命科学资讯

Novartis cuts hundreds of jobs; Novo’s dual-acting diabetes drug heading to Phase 3

Otsuka gains approval for first-of-its-kind treatment against rare kidney disease

CMS sets 2027 Medicare prices for Wegovy, Trelegy and 13 other drugs